Trial Profile
Phase IIa study to evaluate the effects of GPD-1116 on late phase asthmatic response to allergen challenge in asthmatic patients.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 31 Oct 2011
Price :
$35
*
At a glance
- Drugs GPD 1116 (Primary)
- Indications Allergic asthma
- Focus Therapeutic Use
- 30 Jul 2011 New trial record